vs
Side-by-side financial comparison of Azenta, Inc. (AZTA) and Youlife Group Inc. (YOUL). Click either name above to swap in a different company.
Azenta, Inc. is the larger business by last-quarter revenue ($148.6M vs $127.5M, roughly 1.2× Youlife Group Inc.). Youlife Group Inc. runs the higher net margin — 4.1% vs -10.4%, a 14.5% gap on every dollar of revenue.
Azenta, was founded in 1978, and is based in Chelmsford, Massachusetts, United States. The company is a provider of life sciences services including genomics, cryogenic storage, automation, and informatics.
AZTA vs YOUL — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $148.6M | $127.5M |
| Net Profit | $-15.4M | $5.2M |
| Gross Margin | 42.9% | 14.1% |
| Operating Margin | -4.9% | 5.0% |
| Net Margin | -10.4% | 4.1% |
| Revenue YoY | 0.8% | — |
| Net Profit YoY | -15.7% | — |
| EPS (diluted) | $-0.34 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $148.6M | — | ||
| Q3 25 | $159.2M | — | ||
| Q2 25 | $143.9M | $127.5M | ||
| Q1 25 | $143.3M | — | ||
| Q4 24 | $147.4M | — | ||
| Q3 24 | $150.6M | — | ||
| Q2 24 | $144.3M | — | ||
| Q1 24 | $136.4M | — |
| Q4 25 | $-15.4M | — | ||
| Q3 25 | $50.9M | — | ||
| Q2 25 | $-48.0M | $5.2M | ||
| Q1 25 | $-47.7M | — | ||
| Q4 24 | $-11.0M | — | ||
| Q3 24 | $-6.6M | — | ||
| Q2 24 | $-6.6M | — | ||
| Q1 24 | $-137.4M | — |
| Q4 25 | 42.9% | — | ||
| Q3 25 | 45.4% | — | ||
| Q2 25 | 46.2% | 14.1% | ||
| Q1 25 | 43.8% | — | ||
| Q4 24 | 46.7% | — | ||
| Q3 24 | 45.5% | — | ||
| Q2 24 | 44.8% | — | ||
| Q1 24 | 43.8% | — |
| Q4 25 | -4.9% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | -1.3% | 5.0% | ||
| Q1 25 | -12.7% | — | ||
| Q4 24 | -5.9% | — | ||
| Q3 24 | -3.1% | — | ||
| Q2 24 | -4.9% | — | ||
| Q1 24 | -18.1% | — |
| Q4 25 | -10.4% | — | ||
| Q3 25 | 32.0% | — | ||
| Q2 25 | -33.4% | 4.1% | ||
| Q1 25 | -33.3% | — | ||
| Q4 24 | -7.5% | — | ||
| Q3 24 | -4.4% | — | ||
| Q2 24 | -4.5% | — | ||
| Q1 24 | -100.8% | — |
| Q4 25 | $-0.34 | — | ||
| Q3 25 | $1.12 | — | ||
| Q2 25 | $-1.05 | — | ||
| Q1 25 | $-1.04 | — | ||
| Q4 24 | $-0.25 | — | ||
| Q3 24 | $-0.25 | — | ||
| Q2 24 | $-0.12 | — | ||
| Q1 24 | $-2.48 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $336.6M | $22.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.7B | $-55.7M |
| Total Assets | $2.1B | $148.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $336.6M | — | ||
| Q3 25 | $279.8M | — | ||
| Q2 25 | $270.0M | $22.2M | ||
| Q1 25 | $253.6M | — | ||
| Q4 24 | $377.5M | — | ||
| Q3 24 | $280.0M | — | ||
| Q2 24 | $336.5M | — | ||
| Q1 24 | $353.5M | — |
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.7B | $-55.7M | ||
| Q1 25 | $1.7B | — | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.8B | — | ||
| Q2 24 | $2.0B | — | ||
| Q1 24 | $2.2B | — |
| Q4 25 | $2.1B | — | ||
| Q3 25 | $2.1B | — | ||
| Q2 25 | $2.0B | $148.8M | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.3B | — | ||
| Q1 24 | $2.6B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.8M | — |
| Free Cash FlowOCF − Capex | $14.7M | — |
| FCF MarginFCF / Revenue | 9.9% | — |
| Capex IntensityCapex / Revenue | 4.2% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $30.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.8M | — | ||
| Q3 25 | $2.2M | — | ||
| Q2 25 | $25.8M | — | ||
| Q1 25 | $14.4M | — | ||
| Q4 24 | $29.8M | — | ||
| Q3 24 | $17.7M | — | ||
| Q2 24 | $9.8M | — | ||
| Q1 24 | $8.7M | — |
| Q4 25 | $14.7M | — | ||
| Q3 25 | $-5.7M | — | ||
| Q2 25 | $15.0M | — | ||
| Q1 25 | $7.0M | — | ||
| Q4 24 | $22.0M | — | ||
| Q3 24 | $8.3M | — | ||
| Q2 24 | $1.3M | — | ||
| Q1 24 | $428.0K | — |
| Q4 25 | 9.9% | — | ||
| Q3 25 | -3.6% | — | ||
| Q2 25 | 10.4% | — | ||
| Q1 25 | 4.9% | — | ||
| Q4 24 | 15.0% | — | ||
| Q3 24 | 5.5% | — | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | 0.3% | — |
| Q4 25 | 4.2% | — | ||
| Q3 25 | 4.9% | — | ||
| Q2 25 | 7.5% | — | ||
| Q1 25 | 5.2% | — | ||
| Q4 24 | 5.3% | — | ||
| Q3 24 | 6.2% | — | ||
| Q2 24 | 5.9% | — | ||
| Q1 24 | 6.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AZTA
| Multiomics | $67.2M | 45% |
| Core Products | $47.6M | 32% |
| Sample Repository Solutions | $33.8M | 23% |
YOUL
Segment breakdown not available.
